Join
Live feed
·
INSIDERFilingvia Quantisnow
Exagen Inc. logo

President and CEO Aballi John sold $56,827 worth of shares (15,698 units at $3.62) and was granted 2,535 shares, decreasing direct ownership by 2% to 689,834 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
XGN· Exagen Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track XGN (Exagen Inc.) and more on Quantisnow.

President and CEO Aballi John sold $56,827 worth of shares (15,698 units at $3.62) and was granted 2,535 shares, decreasing direct ownership by 2% to 689,834 units (SEC Form 4) | Quantisnow